Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress
Business Wire•25/09/2026•08:30 ET
0
Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present new data from its portfolio of treatments for Duchenne muscular dystrophy at the 31(st) Annual Congress of the World Muscle Society (WMS), taking place Sept. 29 - Oct. 3, in Hiroshima, Japan.
Get started
Create a free account to read the full story and Whiz Insights.